Evidence map›Paper›PMID 34168439›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease2021

Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.

Kentaro Tamaki, Eishin Sakihara, Hiroaki Miyata, Norimichi Hirahara, Oksana Kirichek, Ryosuke Tawara, Shoko Akiyama, Masayuki Katsumata, Mei Haruya, Takeo Ishii and 4 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study.International journal of chronic obstructive pulmonary disease · 2022
    Article
  11. Letter to Editor Regarding the OCEAN Study [Letter].International journal of chronic obstructive pulmonary disease · 2021
    Article
  12. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Kentaro TamakiDepartment of Breast Surgery, Nahanishi Clinic, Okinawa, Japan.
Eishin SakiharaLifestyle Related Disease Medical Center, Naha Medical Association, Okinawa, Japan.
Hiroaki MiyataHealth Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Norimichi HiraharaHealth Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Oksana KirichekValue Evidence and Outcomes, GSK, Stockley Park, UK.
Ryosuke TawaraJapan Development, GSK, Tokyo, Japan.ORCID 0000-0003-4308-8260
Shoko AkiyamaJapan Development, GSK, Tokyo, Japan.ORCID 0000-0002-4388-6089
Masayuki KatsumataJapan Development, GSK, Tokyo, Japan.
Mei HaruyaGovernment Affairs and Market Access, GSK, Tokyo, Japan.
Takeo IshiiMedical Japan, GSK, Tokyo, Japan.
Edgar P SimardValue Evidence and Outcomes, GSK, Collegeville, PA, USA.
Bruce E MillerValue Evidence and Outcomes, GSK, Collegeville, PA, USA.ORCID 0000-0003-3904-3182
Ruth Tal-SingerValue Evidence and Outcomes, GSK, Collegeville, PA, USA.ORCID 0000-0002-5275-8062
Toshihiko KaiseJapan Development, GSK, Tokyo, Japan.ORCID 0000-0001-6059-7900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: A considerable proportion of patients with chronic obstructive pulmonary disease (COPD) remain undiagnosed and untreated even though they may have a burden of respiratory symptoms that impact quality of life. The OCEAN study assessed the ability of screening questionnaires to identify individuals with, or at risk of, COPD by comparing questionnaire outcomes with spirometric measures of lung function. Methods: This observational study included participants ≥40 years of age presenting for their annual health examination at a single medical center in Okinawa, Japan. Participants completed COPD screening questionnaires (CAPTURE and COPD-Q), the Chronic Airways Assessment Test (CAAT), and general demographic and health-related questionnaires. The performance characteristics of CAPTURE and COPD-Q were compared with spirometry-based airflow limitation by calculating the area under the receiver operating characteristic (ROC-AUC) curve. Results: A total of 2518 participants were included in the study; 79% of whom were <60 years of age (mean 52.0 years). A total of 52 (2.1%) participants had airflow limitation defined as forced expiratory volume in 1 second (FEV Conclusion: This study demonstrated that CAPTURE and COPD-Q appear to be effective screening tools for identifying symptomatic individuals with undiagnosed, or at risk of developing COPD in adults ≥40 years of age in Okinawa. Furthermore, early diagnosis and management of PRISm is important to improve future outcomes and the societal burden of disease.

Indexed as

Pulmonary Disease, Chronic ObstructiveQuality of LifeAdultForced Expiratory VolumeHumansJapanMiddle AgedSpirometrySurveys and QuestionnairesVital CapacityCAATCAPTURECOPDCOPD-QJapanPRISm

Identifiers

PMID34168439
PMCPMC8216667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.